Herpes simplex virus type 1 interaction with myeloid cells in vivo by Shivkumar, M et al.
1 
 
Herpes simplex virus type 1 interaction with myeloid cells in vivo 1 
 2 
Maitreyi Shivkumar1,3, Clara Lawler2, Ricardo Milho1,4, Philip G. Stevenson1,2,5 3 
 4 
1Division of Virology, Department of Pathology, University of Cambridge, UK 5 
2School of Chemistry and Molecular Biosciences, University of Queensland and Royal 6 
Children’s Hospital, Brisbane, Australia. 7 
3Current address: Division of Infection and Immunity, University College London, London, UK 8 
4Current address: Costello Medical Consulting, Cambridge, UK 9 
5Correspondence to: Dr. P.G. Stevenson, Level 4 Building 76, School of Chemistry and 10 
Molecular Biosciences, University of Queensland, St Lucia, Brisbane, Queensland 4072, 11 
Australia. tel. +61-7-3636-1614; fax. +61-7-3636-1401; email p.stevenson@uq.edu.au 12 
 13 
14 
JVI Accepted Manuscript Posted Online 20 July 2016
J. Virol. doi:10.1128/JVI.00881-16
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
 o
n
 August 1, 2016 by UC London Library Services
http://jvi.asm.org/
D
ow
nloaded from
 
2 
 
Abstract 15 
Herpes simplex virus type 1 (HSV-1) enters mice via olfactory epithelial cells, then colonizes 16 
the trigeminal ganglia (TG). Most TG nerve endings are subepithelial, so this colonization 17 
implies subepithelial viral spread, where myeloid cells provide an important line of defence. 18 
The outcome of myeloid cell infection by HSV-1 in vitro depends on their differentiation 19 
state; the outcome in vivo is unknown. Epithelial HSV-1 commonly infected myeloid cells, 20 
and cre-lox virus marking showed nose and lung infections passing through lysM+ and 21 
CD11c+ cells. By contrast subcapsular sinus macrophages (SSM) exposed to lymph-borne 22 
HSV-1 were permissive only when type 1 interferon (IFN-I) signaling was blocked; normally 23 
their infection was suppressed. Thus the myeloid infection outcome helped to determine 24 
HSV-1 distribution: subepithelial myeloid cells provided a route of spread from the olfactory 25 
epithelium to TG neurons, while SSM blocked systemic spread. 26 
27 
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Importance 28 
Herpes simplex virus type 1 (HSV-1) infects most people and can cause severe disease. This 29 
reflects its persistence in nerve cells that connect to the mouth, nose, eye and face. 30 
Established infection seems impossible to clear. Therefore we must understand how it 31 
starts. This is hard in humans, but mice show HSV-1 entry via the nose then spread to its 32 
preferred nerve cells. We show that this spread proceeds in part via myeloid cells, which 33 
normally function in host defence. Myeloid infection was productive in some settings, but 34 
was efficiently suppressed by interferon in others. Therefore interferon acting on myeloid 35 
cells can stop HSV-1 spread and enhancing this defence offers a way to improve infection 36 
control. 37 
 38 
39 
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Introduction 40 
 The α-, β- and γ-herpesviruses establish broadly neuro-, myelo- and lymphotropic 41 
persistent infections (1). Less is known about acute infection, as sporadic transmission and 42 
late clinical presentation make it hard to analyse. Acutely adaptive immunity exerts little 43 
restraint on viral tropism, so common themes are likely. The difficulty of clearing established 44 
infections makes these themes important to understand. Genomic comparisons indicate 45 
that herpesvirus infections long pre-date human speciation (2). Therefore related 46 
mammalian herpesviruses are likely to share mechanisms of host colonization, allowing 47 
those of experimentally tractable hosts to provide new insights. Murid herpesviruses have 48 
particular value in this regard, as their hosts provide the main in vivo experimental model of 49 
mammalian biology. 50 
 Murid Herpesvirus-4 (MuHV-4, a gamma-herpesvirus), Murine cytomegalovirus 51 
(MCMV, a beta-herpesvirus) and HSV-1 (an alpha-herpesvirus) all enter mice via olfactory 52 
neurons (3-5). MuHV-4 and MCMV spread thence to lymph nodes (LN) (4, 6), while HSV-1 53 
spreads to the TG (5). Nonetheless each virus penetrates the epithelium and so will 54 
encounter subepithelial myeloid cells. While these normally provide an early defence 55 
against invading pathogens, MCMV exploits them to spread (7) and persist (8), and MuHV-4 56 
exploits them to reach B cells (9). How HSV-1 interacts with myeloid cells is less well 57 
understood. 58 
 Ex vivo human blood-derived monocytes resist productive HSV-1 infection, but 59 
become susceptible after culture (10). Murine macrophages are similar (11, 12). Human 60 
monocyte-derived dendritic cells (DC) support productive infection when immature and lose 61 
susceptibility with maturation (13). Again murine DC appear to be similar (14). MCMV (8) 62 
and HCMV (15) establish latent infections of myeloid cells that are reactivated by 63 
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maturation signals (8). MuHV-4 also establishes latency in myeloid cells (16), but with a 64 
strong tendency to lytic reactivation. It inhibits myeloid cell functions extensively when lytic, 65 
and minimally when latent (17). HSV-1 also impairs myeloid cell functions (18), causing host 66 
shutoff even when infection is abortive (19). Herpesvirus infections remain immunogenic 67 
because uninfected cells can engage in cross-priming. Therefore the purpose of viral evasion 68 
in infected myeloid cells is probably to delay their recognition (20, 21). For MCMV and 69 
MuHV-4 this makes sense, as they use myeloid infection to reach other cell types. The 70 
relevance for HSV-1 is less clear. 71 
 Myeloid cell depletions increase murine susceptibility to HSV-1-induced disease (22, 72 
23), presumably because uninfected myeloid cells protect via immune priming and type I 73 
interferon (IFN-I) production (24-26). Infected myeloid cells might also promote anti-viral 74 
responses. However how in vitro myeloid cell phenotypes relate to those encountered in 75 
vivo is hard to know. A fundamental question is whether in vivo myeloid cell infection is 76 
productive. Key contexts are when incoming virions first encounter subepithelial myeloid 77 
cells, and when infection spreads to the myeloid sentinels of lymph nodes (LN). We show by 78 
cre-mediated genetic marking that HSV-1 can pass productively through the subepithelial 79 
myeloid cells of infected mice. LN myeloid cells contrastingly restricted infection, unless IFN-80 
I signalling was blocked. 81 
 82 
83 
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Materials and Methods 84 
Mice  C57BL/6J (Animal Resources Centre, Perth, Australia; or Harlan Ltd, Oxford, 85 
UK), CD11c-Cre (27) and LysM-cre mice (28) were maintained at University of Queensland or 86 
University of Cambridge animal units and infected when 6–12 weeks old. Experiments were 87 
approved by the University of Queensland Animal Ethics Committee in accordance with 88 
Australian National Health and Medical Research Council guidelines (project 301/13), and by 89 
the University of Cambridge ethical review board and the UK Home Office under the 1986 90 
Animal (Scientific Procedures) Act (Project 80/2538). For nasal infections, virus (106 p.f.u. in 91 
5μl) was pipetted onto the nares of mice held prone under light restraint without 92 
anesthesia, and was spontaneously inhaled (29). For lung infections, mice were anesthetised 93 
with isoflurane and virus (106 p.f.u.) was inhaled in 30μl. For whisker pad infections, mice 94 
were anesthetised with isoflurane, virus (106 p.f.u. in 20µl) was applied to each whisker pad, 95 
and 20 scratches were made through each drop with a 27 gauge needle. Ear pinna infections 96 
were similarly by scarification under anesthesia, applying virus (106 p.f.u. in 20µl) to the left 97 
ear pinna and making 20 scratches made through the drop. Footpad infections (106 p.f.u. in 98 
50µl) were by injection under isoflurane anesthesia. To deplete NK cells, mice were injected 99 
intraperitoneally (i.p.) with 200µg purified mAb PK136 (anti-NK1.1, Bio-X-cell), 1 and 3 days 100 
before infection and every 2 days thereafter. Cell depletion was >90% effective, as 101 
measured by flow cytometry of spleen cells with an antibody to NKp46. To block IFN-I 102 
responses we have mice i.p. 200µg purified mAb MAR1-5A3 (Bio-X-Cell), 1 day before 103 
infection and every 2 days thereafter. This mAb binds to the IFN-I receptor (IFNAR) and 104 
prevents IFN-I binding. Experimental groups were compared statistically by Student's 2 105 
tailed unpaired t test. 106 
 107 
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Cells  Macrophages were recovered by post-mortem peritoneal lavage, followed by 108 
removal of non-adherent cells. They were >90% F4/80+ by immunostaining. Embryonic 109 
fibroblasts were harvested from day 13-14 mouse embryos by trypsin digestion and gentle 110 
tissue grinding. These cells, BHK-21 fibroblasts (American Type Culture Collection (ATCC) 111 
CCL-10), NIH-3T3-cre fibroblasts (30), RAW-264 monocyte / macrophages (ATCC TIB-71), 112 
K562 myeloid leukemia cells (ATCC CCL-243), THP-1 monocytes (ATCC TIB-202), and U937 113 
histiocytic lymphoma cells (ATCC CRL-1593) were grown in Dulbecco's modified Eagle's 114 
medium supplemented with 2mM glutamine, 100IU/ml penicillin, 100µg/ml streptomycin 115 
and 10% fetal calf serum (complete medium). 116 
 117 
Viruses MHV-RG is a derivative of MuHV-4 with a viral M3 (lytic) promoter between 118 
the 3' ends of ORFs 57 and 58 driving loxP-flanked mCherry upstream of GFP (9). MHV-RG 119 
expresses mCherry, but loxP site recombination by cre excises the mCherry coding 120 
sequence, switching the virus irreversibly to GFP expression from the same promoter (MHV-121 
G). We used HSV-1 strain SC16 (31). The HSV-GFP derivative has an HCMV IE1 promoter 122 
transcribing GFP from the US5 locus (5). To make HSV-RG, the loxP-mCherry-pA-loxP-GFP 123 
construct of MHV-RG was amplified with Pfu polymerase (Promega Corporation), adding 124 
HinDIII and BamHI restriction sites to its respective 5' and 3' ends. The PCR product was 125 
cloned into the same sites of pcDNA3 (Invitrogen Corporation), then sub-cloned into pHD5-126 
CRE (32) using an SpeI restriction site in the HCMV IE1 promoter, and XhoI sites in the 127 
pcDNA3 polylinker and downstream of the cre coding sequence in pHD5-CRE. Thus, HCMV 128 
IE1-loxP-mCherry-pA-loxP-GFP-pA was inserted into US5 (genomic site 137945, Genbank 129 
X14112). The plasmid was linearised with ScaI and co-transfected with HSV-1 SC16 viral DNA 130 
into BHK-21 cells using Fugene-6 (Roche Diagnostics). MCherry+ virus was identified under 131 
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ultraviolet illumination, enriched by flow cytometric sorting of infected cells, and plaque-132 
purified by limiting dilution. We derived switched HSV-RG (HSV-G) by passage in NIH-3T3-cre 133 
cells and limiting dilution cloning in BHK-21 cells. All viruses were checked by sequence 134 
across the US5 insertion site and by restriction enzyme mapping of viral DNA. Virus stocks 135 
were grown in BHK-21 cells (5). Virus was recovered from infected cells and supernatants by 136 
ultracentrifugation (38,000 x g, 90min). The pelleted cells were sonicated to break up 137 
aggregates then stored in aliquots at -80oC. 138 
 139 
Virus assays  Virus stocks, cells and organ homogenates were titered for infectivity 140 
by plaque assay. Virus dilutions were incubated with BHK-21 cell monolayers (37oC, 2h), 141 
overlaid with complete medium plus 0.3% carboxymethylcellulose and cultured at 37oC. 142 
After 2 days (HSV-1) or 4 days (MuHV-4) the monolayers were fixed in 4% formaldehyde and 143 
stained with 0.1% toluidine blue. Plaques were counted under x30 microscopy. To measure 144 
both pre-formed infectious and reactivatable MuHV-4, freshly isolated PLN or spleen cell 145 
suspensions were co-cultured with BHK-21 cells for 4 days and plaques detected as above. 146 
To measure both pre-formed infectious and reactivatable HSV-1, TG were disrupted gently, 147 
then incubated (37oC, 30min) with Liberase TL (2WU/ml) and DNase I (0.2mg/ml) (Roche 148 
Diagnostics). The released cells were plated on BHK-21 cell monolayers and cultured for 2 149 
days before fixation, staining and plaque counting. Viral fluorochrome switching was 150 
determined by plaque or infectious centre assay at limiting dilution in 96-well plates (16 151 
wells per dilution). After 2 days (HSV-1) or 4 days (MuHV-4), wells were scored under UV 152 
illumination for green (GFP+, switched) and red (mCherry+, unswitched) fluorescence to 153 
derive titers for each. We calculated % switching as 100 x green titer/( red titer + green 154 
titer). 155 
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 156 
Immunostaining of tissue sections   Organs were fixed in 1% formaldehyde / 157 
10mM sodium periodate / 75mM L-lysine (18h, 4°C). Noses were decalcified by gentle 158 
agitation in 150mM NaCl / 50mM TrisCl (pH=7.2) / 270mM EDTA for two weeks at 23oC, 159 
changing the solution every 2-3 days. All tissues were then equilibrated in 30% sucrose (24h, 160 
4°C) and frozen in OCT. Sections (6μm) were air-dried (1h, 23°C), washed 3x in PBS, blocked 161 
with 0.3% Triton X-100 / 5% normal donkey serum (1h, 23°C), then incubated (18h, 4°C) with 162 
combinations of primary antibodies to: GFP (rabbit pAb or goat pAb, AbCam), B220 (rat 163 
monoclonal Ab (mAb) RA3-6B2, Santa Cruz Biotechnology), CD68 (rat mAb FA-11, AbCam), 164 
α-tubulin (rat mAb YL1/2, Serotec), βIII-tubulin (mouse mAb TU-20, AbCam), CD31 (rat mAb 165 
ER-MP12, Serotec), F4/80 (rat mAb CI:A3–1, Santa Cruz Biotechnology), mCherry (rabbit 166 
pAb, Badrilla), CD169 (rat mAb 3D6.112, Serotec), and polyclonal rabbit sera to MuHV-4 167 
(raised in-house by x3 subcutaneous virus inoculation) and HSV-1 (rabbit pAb, either from 168 
Sigma Chemical Co or raised in house by immunizing rabbits subcutaneously x3 with HSV-1 169 
SC16). After incubation, sections were washed 3× in PBS, incubated (1h, 23°C) with 170 
combinations of Alexa568 or Alexa647-donkey anti-rat IgG pAb, Alexa488- or Alexa568-171 
donkey anti rabbit IgG pAb (Life Technologies), and Alexa488-donkey anti-goat pAb 172 
(Abcam), then washed 3× in PBS, counterstained with DAPI and mounted in Prolong Gold 173 
(Life Technologies). Fluorescence was visualized with Zeiss LSM 510/710 or Leica TCS SP2 174 
confocal microscopes, or a Nikon epifluorescence microscope, and analyzed with Zen 175 
imaging software or ImageJ. 176 
 177 
Immunofluorescence of cells  Cells were seeded on glass coverslips then infected and 178 
18h later fixed in 2% paraformaldehyde / PBS, permeabilized in 0.1% Triton X-100, blocked 179 
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with 5% goat serum, and incubated with rabbit anti-HSV-1 pAb followed by Alexa488-180 
conjugated goat anti-rabbit pAb (Invitrogen). Cellular actin was stained with TRITC-181 
conjugated phalloidin (Sigma Chemical Co). Nuclei were stained with DAPI. Cells were 182 
mounted in Prolong Gold (Invitrogen) and imaged on a Leica TCS SP2 confocal microscope. 183 
 184 
Flow cytometry  Fibroblasts were trypsinized, washed in PBS and analyzed on a 185 
FACSCalibur (BD Biosciences). MCherry and GFP fluorescence were visualized directly. To 186 
identify NK cells, dissociated spleen cells were blocked with anti-CD16/32 (BD Biosciences), 187 
incubated with biotinylated anti-NKp46 mAb (Biolegend) then Alexa488-conjugated 188 
streptavidin (Invitrogen), then washed x2 in PBS and analysed on a FACS Calibur (BD 189 
Biosciences). 190 
 191 
Immunoblotting  Cells were lysed (4oC, 30min) in 1% Triton X-100, 50 mM TrisCl 192 
pH=7.4, 150 mM NaCl, with Complete protease inhibitors (Roche Diagnostics). Cell debris 193 
and nuclei were removed by centrifugation (13,000 x g, 15 min). Lysates were heated to 194 
70˚C in Laemmli’s buffer, followed by SDS-PAGE and electrophoretic transfer to 195 
nitrocellulose membranes. Blots were probed with mouse mAbs CB24 to gB (33) and LP1 to 196 
VP16 (34) and developed with rabbit anti-mouse IgG pAb and LI-COR imaging. 197 
 198 
199 
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Results 200 
HSV-1 infects myeloid cells at its likely natural entry site 201 
 Most experimental HSV-1 infections are initiated by scarification. Natural infection is 202 
more likely to occur at an intact mucosal surface. HSV-1 fails to infect non-scarified mice 203 
orally but infects them nasally via olfactory neurons (5). Nasal infection showed extensive 204 
sub-epithelial spread (Fig.1a). Epithelial infection was always present, and early infection is 205 
solely epithelial (5), but sub-epithelial infection evidently spread faster. Myeloid cells 206 
(CD68+) were abundantly recruited to subepithelial infection sites, whether from primary 207 
olfactory infection or secondary spread to the respiratory epithelium (Fig.1b). Many of these 208 
infiltrating cells expressed viral lytic antigens (Fig.1c). Therefore HSV-1 commonly infected 209 
subepithelial myeloid cells after mucosal host entry. 210 
 211 
HSV-1 strain SC16 replicates in RAW-264 monocyte / macrophages 212 
 HSV-1 strain SC16, a low passage isolate derived in the 1970s, was used to establish 213 
anti-viral chemotherapy (35) and a glycoprotein H-deficient vaccine (36). Its tropism for 214 
myeloid cells has not been tested. It replicated in RAW-264 monocyte / macrophages 215 
(Fig.2a). Productive infection was validated by immunoblotting for the virion gB and VP16 216 
(Fig.2b). However RAW-264 cells produced fewer infectious virions than BHK-21 fibroblasts 217 
(Fig.2a), and after overnight infection (3 p.f.u. / cell), 16.8% of RAW-264 cells expressed viral 218 
lytic antigens (Fig.2c), whereas >99% of BHK-21 cells did so (data not shown). Three human 219 
myeloid cell lines - K562, THP-1 and U937 - supported productive infection even less well 220 
than RAW-264 cells (Fig.2a). Therefore SC16 was similar to other HSV-1 strains in showing a 221 
modest capacity to replicate in myeloid cells in vitro. 222 
 223 
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HSV-RG allows cell-type specific virus tracking 224 
 Viral lytic gene expression in CD68+ cells (Fig.1) suggested productive myeloid 225 
infection. To track this functionally we generated a floxed reporter virus HSV-RG, inserting in 226 
the non-essential US5 locus (37) a human CMV IE1 promoter driving a floxed mCherry 227 
coding sequence plus poly-A site, upstream of a GFP coding sequence plus poly-A site 228 
(Fig.3a). HSV-RG expressed mCherry (red fluorescence), until mCherry excision by cre 229 
irreversibly switched its fluorochrome expression to GFP (green) (Fig.3b). The unswitched 230 
HSV-RG and switched HSV-G showed no difference in replication in cre+ or cre- cells in vitro 231 
(Fig.3c). Both showed minor in vivo attenuation after nasal inoculation relative to the 232 
parental HSV-1 SC16 wild-type, presumably due to US5 disruption, but no defect relative to 233 
each-other (Fig.3d). Therefore HSV-RG provided a tool capable of unbiased viral tracking 234 
through cre+ cells. 235 
 236 
HSV-RG is recombined by lysM-cre mice 237 
 A cellular path connects each recovered virion to host entry. Virus tagging tells us 238 
what proportion of productive paths traversed a cre+ cell. LysM-cre mice express cre mainly 239 
in neutrophils, mature macrophages (28, 38, 39), and type 2 alveolar epithelial cells (40). 240 
HSV-RG accordingly showed fluorochrome switching in peritoneal macrophages but not 241 
embryonic fibroblasts of lysM-cre mice (Fig.4a). We compared lung infection by HSV-RG 242 
with MuHV-4 carrying a similar switching cassette (MHV-RG) (Fig.4b, 4c). Gr1+ neutrophils 243 
and inflammatory monocytes cells entering the lungs do not express lysM (40); and neither 244 
MuHV-4 nor HSV-1 infects type 2 alveolar epithelial cells (41). Thus at least acutely, viral 245 
fluorochrome switching could be interpreted as replication in alveolar macrophages. MuHV-246 
4 enters the lungs via alveolar macrophages (40) and MHV-RG accordingly showed 247 
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substantial switching after 1 day. HSV-1 infects mainly type 1 alveolar epithelial cells (40) 248 
but also showed substantial switching at days 1 and 2 post-inoculation. 249 
 Herpesviruses given nasally (i.n.) also infect the upper respiratory tract (29). 250 
Therefore we assayed also the fluorochrome expression of HSV-RG and MHV-RG recovered 251 
from noses (Fig.4c). Upper respiratory tract infection proceeds more slowly than lung 252 
infection, so we sampled the mice at day 3. HSV-RG and MHV-RG were both less switched in 253 
noses than in lungs, so fewer virions followed paths through lysM+ cells, but switching was 254 
detectable nonetheless. 255 
 Nasal HSV-1 spreads to the trigeminal ganglia (TG) after 2-3 days and re-emerges in 256 
the facial skin after 4-5 days (5). Thus, virions in the TG should be at least as switched as 257 
those in noses, and those in the skin should be at least as switched as those in the TG. After 258 
lung plus nose infection (large inoculation volume with anesthesia), the HSV-RG recovered 259 
from TG or skin at day 4 was similarly switched to that from noses. Selective upper 260 
respiratory tract infection (low volume inoculation without anesthesia) also showed no 261 
significant differences in switching between HSV-RG from noses, TG and skin (Fig.4e). 262 
Therefore productive myeloid cell infection occurred early, en route from the olfactory 263 
epithelium to the TG. Immunostaining of tissue sections identified mCherry+ and GFP+ 264 
infected cells in the TG (Fig.4f) and in the superficial layers of the skin (Fig.4g). Thus, virus re-265 
emerging from the TG possibly avoids exposure to lysM+ cells because it re-emerges in the 266 
epidermis (5). 267 
 Inoculation of the whisker pad or the ear pinna by scarification, routes commonly 268 
used for experimental HSV-1 infection, gave less switching (Fig.4h). This reflected possibly 269 
that scarification provides direct access to sub-epithelial nerve endings, bypassing the 270 
normal myeloid cell defences of intact epithelia. 271 
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 272 
HSV-RG is recombined by CD11c-cre mice 273 
 Myeloid cells are highly diverse. No single promoter identifies them all or defines 274 
exclusive sub-populations (42). Thus to back-up the results with lysM-cre mice,  we tracked 275 
HSV-RG fluorochrome switching in CD11c-cre mice. Immunostaining shows CD11c 276 
expression in DC and some macrophage populations, including lymph node (LN) subcapsular 277 
sinus macrophages (SSM) (43). Few DC express lysM (28). Thus, CD11c and lysM expression 278 
identify partly overlapping populations, with CD11c-cre mice measuring HSV-1 passage 279 
through more DC-type myeloid cells. 280 
 As in lysM-cre mice, HSV-RG was more switched in CD11c-cre lungs than in noses, 281 
although switching was detectable in both sites (Fig.5a). A direct comparison of CD11c-cre 282 
and LysM-cre i.n. infections at day 4 (Fig.5b) showed somewhat more switching in CD11c-283 
cre mice for both noses and TG. Each transgenic showed more switching in noses than in TG. 284 
This was statistically significant for CD11c-cre mice but not for LysM-cre. Analysing larger 285 
numbers of i.n.-infected CD11c-cre mice at day 5 (Fig.5c) confirmed greater switching in 286 
noses than in TG. 287 
 288 
Type I interferons (IFN-I) restrict HSV-1 infection of myeloid cells 289 
 Viral fluorochrome switching is irreversible, and so should increase cumulatively 290 
between infection sites. Thus, the decrease in HSV-RG switching from noses to TG indicated 291 
that although CD11c+ cells generated new virions, they passed infection to neurons less well 292 
than CD11c- cells. Switched and unswitched viruses had equal fitness, so this result 293 
suggested that replication in CD11c+ cells carried an extra cost, for example due to innate 294 
immune stimulation. CD11c+ cells readily pass MuHV-4 to LN (6, 9). By contrast HSV-1 lung 295 
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and nose infections gave <50 p.f.u. per LN (data not shown). HSV-1 may lack the capacity to 296 
exploit DC migration. However virions should still reach LN via the lymph. Therefore we 297 
considered that CD11c+ cell infection might inhibit HSV-1 propagation by local immune 298 
activation, for example by eliciting IFN-I, which has anti-HSV-1 activity in both humans and 299 
mice (44-46). The LN subcapsular sinus is a prominent site of IFN-I responses (47), and 300 
Herpes virions inoculated into footpads (i.f.) directly reach CD11c+ subcapsular sinus 301 
macrophages (SSM) (39, 43). Therefore to test in vivo how IFN-I affected HSV-1 myeloid cell 302 
infection, we gave mice i.p. anti-IFNAR antibody or not, then i.f. GFP+ HSV-1 (Fig.6). 303 
 At 1 day post-inoculation, IFNAR blockade had no significant effect on HSV-1 titers in 304 
footpads but increased substantially titers in the popliteal LN (PLN) (Fig.6a). By day 3, IFNAR 305 
blockade had increased footpad titers, PLN titers remained elevated, and infection had 306 
spread to the liver and spleen (Fig.6b), implying passage from the PLN to the blood. 307 
Immunostaining PLN sections at day 1 (Fig.6c, 6d) showed significantly more viral GFP+ and 308 
viral antigen+ cells around the subcapsular sinus after IFNAR blockade. Both viral markers 309 
co-localized with CD68 and CD169, indicating SSM infection. The few infected cells of 310 
control mice also included examples of co-localization with CD68 and CD169. By day 3 311 
substantial inflammatory infiltrate into the PLN of IFNAR-blocked mice was evident by CD68+ 312 
staining (Fig.6e, compare Fig.6d). CD169 expression was largely lost but expression of the 313 
tissue macrophage marker F4/80, which SSM lack (48), was increased, and both CD68+ and 314 
F4/80+ cells were HSV-1 antigen+. B220+ B cells and CD31+ vascular endothelial cells showed 315 
no infection. Therefore IFNAR blockade increased HSV-1 infection specifically in SSM and 316 
other myeloid cells. 317 
 One action of IFN-I at the subcapsular sinus is NK cell recruitment (49). To test 318 
whether this could account for the protection of SSMs against HSV-1 by IFN-I, we compared 319 
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IFNAR blockade with NK1.1+ cell depletion in C57Bl/6 mice. NK cell depletion significantly 320 
increased day 1 PLN virus titers (Fig.6f). However IFNAR blockade increased them more, and 321 
while IFNAR blockade increased viral GFP+ cell numbers on PLN sections, NK cell depletion 322 
did not have a significant effect. Therefore NK cells contributed to anti-HSV-1 defence at the 323 
subcapsular sinus but could not account for most IFN-I-dependent protection. The strong 324 
anti-viral efficacy of IFN-I at day 1, with inhibition of both viral reporter and lytic gene 325 
expression, suggested that it acted directly on SSM to block infection at a very early stage. 326 
  327 
Site-specific changes in HSV-RG switching in IFNAR-blocked mice 328 
 We tested next whether IFNAR blockade increased HSV-1 production by myeloid 329 
cells, as measured by fluorochrome switching (Fig.7). IFNAR blockade increased day 3 lung 330 
virus titers in lysM-cre mice (Fig.7a). However the recovered virus showed no increase in 331 
switching. As virus titers were higher, more switched virus was produced, but IFNAR 332 
blockade evidently also increased lysM- cell virus production. Total virus titers also increased 333 
in lysM-cre noses and footpads without increasing the fraction switched (Fig.7b, 7c). 334 
 In TG (Fig.7b), total titers and switching both increased. Therefore IFN-I limited 335 
macrophage-dependent passage to the TG more than macrophage-independent passage, 336 
although the proportion of virus that was switched remained low, so passage through lysM+ 337 
cells to the TG was still an accessory route. By contrast LN virus showed abundant switching 338 
in IFNAR-blocked mice, comparable to that of lungs. LN infection was too low to assess 339 
switching in control mice, but the substantial rise in virus titers and high level of switching 340 
after IFNAR blockade implied copious virus production by lysM+ cells, most likely SSM 341 
(Fig.6). 342 
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 IFNAR blockade of CD11c-cre mice gave similar results: it increased HSV-RG titers in 343 
lungs, noses and footpads without significantly increasing switching; it increased both titers 344 
and switching in TG; and it increased LN titers with abundant switching. Thus, IFN-I 345 
regulated HSV-1 spread to a degree determined by myeloid cell involvement. In LN, it 346 
protected SSM and so blocked viraemic spread. In subepithelial tissues it also moderated 347 
myeloid infection but did not prevent myeloid cell-independent virus passage from the 348 
olfactory epithelium to the TG. Fig.8 outlines our understanding of how myeloid cell 349 
infection fits into the HSV-1 lifecycle. 350 
  351 
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Discussion 352 
 Sentinel macrophages and DC monitor tissues for normal senescence and for 353 
pathogen invasion. They are particularly numerous below epithelial surfaces and where 354 
extracellular fluid enters LN. Thus despite the anatomical restriction of HSV-1 persistence to 355 
local neuronal ganglia, subepithelial spread after mucosal entry led it to myeloid cells. 356 
Comparison with other herpesviruses that enter via the olfactory epithelium (3, 4) reveals 357 
myeloid infection as a common theme, providing access to diverse latency reservoirs. 358 
 The different outcomes of HSV-1, MuHV-4 and MCMV myeloid infections can be 359 
explained in part by the tendency of each virus to initiate lytic or latent gene expression. 360 
MCMV must remain latent in monocytes to reach secondary infection sites such as the 361 
salivary glands; MuHV-4 must remain latent in DC until they contact B cells; each reactivates 362 
presumably in response to microenvironmental signals reaching the myeloid cell nucleus. 363 
HSV-1 has a superficially simpler host colonization strategy of replicating lytically until it 364 
enters a neuron. Its tendency to lytic replication and capacity to infect many cell types make 365 
innate immune defences key to preventing acute disease. IFNAR blockade greatly increased 366 
virus titers, consistent with what is observed in IFNAR-/- mice (45). The fluorochrome 367 
switching of TG virus in lysM-cre and CD11c-cre mice indicated that myeloid cells intercept 368 
some of the HSV-1 penetrating the olfactory epithelium, and through IFN-I hinder its spread 369 
to trigeminal neurons; but the key role of IFN-I was in LN, where its protection of SSM 370 
prevented systemic infection. 371 
 SSM do not form a physical barrier to lymph-borne virus spread, as they merely stud 372 
the subcapsular sinus wall (50). Rather they adsorb viruses from the lymph (51). This 373 
sampling allows SSMs to initiate early innate and adaptive immune responses. Cumulative 374 
virion adsorption along the tortuous lymphatic channels of serial LN also stops lymph-borne 375 
 o
n
 August 1, 2016 by UC London Library Services
http://jvi.asm.org/
D
ow
nloaded from
 
19 
 
virions reaching the blood. The lymph cleansing depends on SSM not supporting replication 376 
of viruses they adsorb, or at least slowing their replication sufficiently for immune responses 377 
to become effective. The importance here of IFN-I was evident from IFNAR blockade 378 
allowing HSV-1 to replicate in SSM and to reach the liver and spleen, consistent with viremic 379 
spread. 380 
 SSM also limit the spread of MuHV-4 and MCMV (39, 43). MuHV-4 bypasses this 381 
restriction by entering LN in DC. The route MCMV takes is yet to be defined, but it is clearly 382 
more permissive than SSM. HSV-1 was able to pass through upper and lower respiratory 383 
tract myeloid cells but not through SSM. As VSV can replicate in SSM (51) it is unclear why 384 
herpesviruses have not evolved to do so. HSV-1 IFN-I evasion (52) may be more complete in 385 
humans than in mice. However the restriction of clinical HSV-1 lesions to a trigeminal 386 
distribution argues that human LN are also an effective barrier to spread. As HSV-1 still 387 
reached neurons when IFN-I signalling was intact, there may be limited selective pressure 388 
for more complete evasion. TG infection increased without IFN-I, but viral evolution is 389 
driven by transmission efficiency whether greater initial HSV-1 delivery to neurons increases 390 
long-term shedding is uncertain. Viral re-emergence from TG neurons is more directly 391 
relevant to transmission. Thus it was of interest that HSV-1 passage from TG to skin seemed 392 
to avoid lysM+ cells, perhaps because most skin infection is epidermal (5). Excessive IFN-I 393 
evasion may have down-sides: IFN-I contributes to the homeostasis of immune cells (53) 394 
and possibly also neurons (54), so complete blockade might compromise persistence in 395 
these cell types. Such compromises forced on persistent viruses provide potential means of 396 
improving infection control. 397 
  398 
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Figure legends 541 
Figure 1. Myeloid cell infection by nasally inoculated HSV-1. 542 
a. Mice were given HSV-1 SC16 i.n. (106 p.f.u. in 5μl). After 3 days, nose sections were 543 
stained for HSV-1 antigens, for α-tubulin to identify olfactory neurons and their apical cilia, 544 
and with DAPI to identify cell nuclei. The boxed region in the upper panel is shown at higher 545 
magnification below. The images are representative of more than 10 mice. 546 
b. Mice were infected as in a. After 3 days, nose sections were stained for HSV-1 antigens, 547 
CD68 (macrophages / DC) and with DAPI (cell nuclei). Examples are shown of a primary 548 
olfactory epithelial infection site and a secondary respiratory epithelial infection site, both 549 
with extensive overlap between viral antigen expression and CD68+ myeloid cell infiltration. 550 
The images are representative of 6 mice examined. 551 
c. Mice were infected as in a. After 1 day nose sections were stained for HSV-1 antigens and 552 
for CD68 as in b. 3 examples of neuroepithelial infection are shown. Arrows show example 553 
CD68+HSV-1+ cells. The right-hand panels show the boxed areas in more detail. 554 
 555 
Figure 2. Myeloid cell infection by HSV-1 SC16 in vitro. 556 
a. BHK-21 fibroblasts, murine RAW-264 monocyte / macrophages, and human myeloid cell 557 
lines (K562, THP-1, U937) were infected with HSV-1 (3 p.f.u. / cell, 1h) then washed in pH = 3 558 
buffer to inactivate remaining extracellular virions and cultured at 37oC (t=0). 3, 8, 18 and 559 
24h later, replicate cultures were assayed for infectivity by plaque assay. Mean ± SD of 2 560 
experiments are shown. BHK-21 cells produced significantly more virus than RAW-264 cells, 561 
and they produced significantly more virus than the human cell lines. 562 
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b. Cells were infected as in a, then lysed, electrophoresed and immunoblotted for the viral 563 
gB (mAb CB24), VP16 (mAb LP1) and cellular actin. The left lane shows molecular weight 564 
markers. 565 
c. RAW-264 cells were infected as in a or left uninfected, cultured (24h, 37oC), fixed, 566 
permeabilized and stained for HSV-1 antigens with a polyclonal serum. Actin was stained 567 
with phalloidin-TRITC and nuclei with DAPI. Of >1000 cells counted, 16.8% were viral 568 
antigen+. 569 
 570 
Figure 3. Characterization of floxed colour switching  HSV-1 (HSV-RG). 571 
a. We inserted into the non-essential HSV-1 US5 locus an expression cassette comprising an 572 
HCMV IE1 promoter, a floxed mCherry coding sequence plus poly A site, and a GFP coding 573 
sequence plus poly A site. LoxP recombination by cre removed the mCherry coding 574 
sequence plus poly A site, switching viral fluorochrome expression from red to green. 575 
b. NIH-3T3-cre cells were accordingly green by epifluorescence microscopy when infected 576 
by HSV-RG (0.01 p.f.u. / cell, 24h), whereas infected cre- BHK-21 cells were red. 577 
c. BHK-21 and NIH-3T3-cre cells were infected (0.01 p.f.u. / cell, 2h) with unswitched (HSV-578 
RG) or switched virus (HSV-G), then washed in pH=3 buffer and cultured in complete 579 
medium. Time = 0 is when virus was added. At each time point replicate cultures were 580 
assayed for red and green fluorescent infectivity by overnight infection of BHK-21 cells in 581 
the presence of phosphonoacetic acid (100μg/ml) to limit infection to a single cycle, and  582 
flow cytometric enumeration of red and green BHK-21 cells. Each point corresponds to 583 
10,000 cells counted. The data show similar growth of HSV-RG and HSV-G in both cell lines 584 
and almost complete switching of HSV-RG in NIH-3T3-cre cells. 585 
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d. C57BL/6 mice were infected i.n. (106 p.f.u. in 5μl without anesthesia) with HSV-RG, HSV-G 586 
or wild-type HSV-1 SC16. 3 or 5 days later, tissues were assayed for infectious virus by 587 
plaque assay. All HSV-RG plaques were red and all HSV-G plaques were green. SC16 plaques 588 
were not fluorescent. Crosses show mean titers, other symbols show individual mice. SC16 589 
titers were greater than HSV-G in noses, greater than HSV-RG in TG, and greater than both 590 
in skin, but the infections were otherwise equivalent. Specifically there was no difference 591 
between HSV-RG and HSV-G. 592 
 593 
Figure 4. HSV-1 replicates in lysM+ cells. 594 
a. Peritoneal macrophages or embryonic fibroblasts (MEF) of lysM-cre mice were infected 595 
with HSV-RG (1 p.f.u./cell, 18h) then visualized by epifluorescence microscopy. >80% of 596 
infected peritoneal macrophages were mCherry-GFP+; all infected fibroblasts were 597 
mCherry+GFP-. 598 
b. LysM-cre or C57BL/6 mice were infected i.n. with HSV-RG, or with MHV-RG as a positive 599 
switching control (106 p.f.u. in 30μl under anesthesia). 1-2 days later lungs were assayed for 600 
red / green switching by plaque assay. Circles show individual mice, dashed bars show 601 
means. No switched virus was recovered from cre- C57BL/6 mice. 602 
c. LysM-cre mice were infected as in b. 3 days later lungs and noses were assayed for red / 603 
green switching by plaque assay. Circles show individual mice, dashed bars show means. 604 
d. LysM-cre mice were infected i.n. with HSV-RG (106 p.f.u. in 30μl under anesthesia). 4 days 605 
later organs were plaque assayed for total infectivity and red / green switching. Circles show 606 
individual mice, dashed bars show means. Switching data were pooled from 2 experiments. 607 
The % switching was not significantly different between noses, TG and skin. 608 
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e. LysM-cre mice were infected i.n. with HSV-RG (106 p.f.u. in 5μl). 4 days later organs were 609 
plaque assayed for total infectivity and red / green switching. Circles show individual mice, 610 
dashed bars show means. Switching data were pooled from 2 experiments. The % switching 611 
was not significantly different between noses, TG and skin. 612 
f. LysM-cre mice were infected as in e. 4 days later TG were stained for viral GFP and 613 
mCherry. Neurons were identified by staining for βIII-tubulin. Nuclei were stained with DAPI. 614 
Arrows show example fluorescent neurons. 615 
g. LysM-cre mice were infected as in e. 4 days later skin sections were stained for viral GFP 616 
and mCherry expression. Nuclei were stained with DAPI. Arrows show fluorescent cells in 617 
the epidermis. 618 
h. LysM-cre mice were infected by scarification of the whisker pad (WP) or the ear pinna 619 
(EP) (106 p.f.u.). 4 days later organs were plaque assayed for red / green switching. DRG = 620 
dorsal root ganglia. Data are pooled from 2 experiments. Circles show individual mice, 621 
dashed bars show means. 622 
 623 
Figure 5. HSV-1 replicates in CD11c+ cells. 624 
a. CD11c-cre mice were infected i.n. with HSV-RG (106 p.f.u. in 30μl under anesthesia). 3 625 
days later lungs and noses were plaque assayed for red / green switching. Circles show 626 
individual mice, crosses show means. 627 
b. CD11c-cre or LysM-cre mice were infected i.n. with HSV-RG (106 p.f.u. in 5μl without 628 
anesthesia). 4 days later noses and TG were plaque assayed for red / green switching. Circles 629 
show individual mice, bars show means. In lysM-cre mice TG switching was less than nose 630 
switching, but not significantly so (p=0.08). In CD11c-cre mice TG switching was significantly 631 
less than nose switching (p<10-5). 632 
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c. CD11c-cre were infected i.n. with HSV-RG (106 p.f.u. in 5μl without anesthesia). 5 days 633 
later noses and TG were plaque assayed for red / green switching. Circles show individual 634 
mice, crosses show means. TG switching was significantly less than nose switching 635 
(p<0.0005). 636 
 637 
Figure 6. IFN-I limits HSV-1 infection of SSM. 638 
a. C57BL/6 mice were given IFNAR blocking antibody (αIFN) or not (cont) then infected i.f. 639 
with HSV-GFP (106 p.f.u.). 1 day later footpads and PLN were plaque assayed for infectious 640 
virus. Crosses show mean titers, other symbols show individuals. The dashed line shows the 641 
lower limit of assay sensitivity. IFNAR blockade significantly increased PLN but not footpad 642 
titers. 643 
b. C57BL/6 mice were given IFNAR blocking antibody or not and infected i.f. with HSV-GFP 644 
as in a. 3 days later virus titers were determined by plaque assay. Crosses show means, 645 
circles show individuals. Dashed lines show assay sensitivity limits. IFNAR blockade 646 
significantly increased all titers. 647 
c. C57BL/6 mice were given IFNAR blocking antibody or not and infected i.f. with HSV-GFP as 648 
in a. 1 day later PLN sections were analysed for viral GFP and antigen expression. Positive 649 
cells were counted across 3 fields of view per section for 3 sections from each mouse. 650 
Circles and squares show mean counts for individuals, bars show group means. IFNAR 651 
blockade significantly increased GFP+ and antigen+ cell numbers. 652 
d. Example images are shown for the mice infected in c. The left hand panels show low 653 
magnification overviews, with viral GFP around the subcapsular sinus after IFNAR blockade 654 
(arrows). The right hand panels show the relationship between viral GFP or antigen staining 655 
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(HSV-1) and the myeloid cell markers cell CD169 and CD68. Arrows show examples of co-656 
localization. 657 
e. C57BL/6 mice were given IFNAR blocking antibody then infected i.f. with HSV-1 SC16 (106 658 
p.f.u.). 3 days later, PLN sections were stained for viral antigens plus markers of 659 
macrophages (CD169, CD68, F4/80), B cells (B220) and vascular endothelium (CD31). The 660 
images are representative of 3 mice per group. Arrows show examples of co-localization. 661 
CD169 staining was largely lost, but HSV-1 staining consistently co-localized with CD68 and 662 
F4/80, and not with B220 or CD31. 663 
f. C57BL/6 mice were given IFNAR blocking antibody (αIFN), anti-NK1.1 depleting antibody 664 
(αNK) or no antibody  (cont), then infected i.f. with HSV-GFP. 1 day later PLN were plaque 665 
assayed for infectious virus. Crosses show means, circles show individuals. The dashed line 666 
shows the lower limit of assay sensitivity. NK depletion significantly increased virus titers, 667 
but IFNAR blockade gave a significantly greater increase. 668 
g. Mice were treated as in f, then assayed for infection 1 day later by counting viral GFP+ 669 
cells on PLN sections (3 fields of view per section for 3 sections from each mouse). Squares 670 
show mean counts for individual mice, bars show group means. IFNAR blockade significantly 671 
increased GFP+ cell numbers relative to controls. NK cell depletion did not. 672 
 673 
Figure 7. IFNAR blockade increases HSV-RG replication in myeloid cells. 674 
a. LysM-cre mice were given IFNAR blocking antibody (αIFN) or not (cont), then infected i.n. 675 
with HSV-RG (106 p.f.u. in 30µl under anesthesia). 3 days later lungs were plaque-assayed 676 
for total infectivity and virus switching. Crosses show means, circles show individuals. IFNAR 677 
blockade increased virus titers but not virus switching. 678 
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b. LysM-cre mice were given IFNAR blocking antibody or not, then infected i.n. with HSV-RG 679 
(106 p.f.u. in 5µl without anesthesia). 3 days later noses and TG  were plaque-assayed for 680 
total infectivity and virus switching. Crosses show means, circles show individuals. IFNAR 681 
blockade increased virus titers in both sites and virus switching only in TG. 682 
b. LysM-cre mice were given IFNAR blocking antibody or not, then infected i.f. with HSV-RG 683 
(106 p.f.u.). 3 days later footpads and PLN  were plaque-assayed for total infectivity and 684 
virus switching. Crosses show means, circles show individuals. IFNAR blockade increased 685 
virus titers in both sites. After IFNAR blockade, PLN virus was significantly more switched 686 
than footpad virus (p<10-4). ND = not determined, due to insufficient plaque numbers. 687 
d. CD11c-cre mice were treated, infected i.n. and analysed as in a. IFNAR blockade increased 688 
virus titers in lungs but not virus switching. 689 
e. CD11c-cre mice were treated, infected i.n. and analysed as in b. IFNAR blockade increased 690 
virus titers in noses and TG and virus switching only in TG. 691 
f. CD11c-cre mice were treated, infected i.f. and analysed as in c. IFNAR blockade increased 692 
virus titers in footpads and PLN. After IFNAR blockade, PLN virus was significantly more 693 
switched than footpad virus (p<10-3). ND = not determined. 694 
 695 
Figure 8. Schematic diagram of HSV-1 host colonization and its relationship to myeloid 696 
cells. 697 
This synthesis draws on the current paper and reference 5. The data are from mice but are 698 
also consistent with what we know of human infection. (1) Incoming virions bind to 699 
olfactory neuronal cilia. Neuronal infection provides a route across the epithelium. (2) 700 
Infection does not spread to the olfactory bulbs, but rather to subepithelial tissues. Here 701 
virions can enter trigeminal neurons directly; they can infect myeloid cells en route; or they 702 
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can enter lymphatics. At least 10% of virions recovered from TG had passed through a 703 
myeloid cell, and at least 25% if IFN-I signalling was blocked. (3) Virions reaching lymph 704 
nodes infect subcapsular sinus macrophages. IFN-I ensures that this infection is non-705 
productive. Virus carried to LN in DC also seems not to spread. (4) Latency is established in 706 
the trigeminal ganglion. There is also acute infection spread between neurons, allowing exit 707 
via new sites such as the skin and oropharynx. (5) Virus delivery to the epidermis bypasses 708 
dermal myeloid cells. 709 
 710 
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